Skip to Content

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit

Updates regarding government operating status and resumption of normal operations can be found at

Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Genome-wide association analysis identifies three new breast cancer susceptibility loci.
Authors: Ghoussaini M,  Fletcher O,  Michailidou K,  Turnbull C,  Schmidt MK,  Dicks E,  Dennis J,  Wang Q,  Humphreys MK,  Luccarini C,  Baynes C,  Conroy D,  Maranian M,  Ahmed S,  Driver K,  Johnson N,  Orr N,  dos Santos Silva I,  Waisfisz Q,  Meijers-Heijboer H,  Uitterlinden AG,  Rivadeneira F,  Netherlands Collaborative Group on Hereditary Breast and Ovarian Cancer (HEBON),  Hall P,  Czene K,  Irwanto A,  Liu J,  Nevanlinna H,  Aittomäki K,  Blomqvist C,  Meindl A,  Schmutzler RK,  Müller-Myhsok B,  Lichtner P,  Chang-Claude J,  Hein R,  Nickels S,  Flesch-Janys D,  Tsimiklis H,  Makalic E,  Schmidt D,  Bui M,  Hopper JL,  Apicella C,  Park DJ,  Southey M,  Hunter DJ,  Chanock SJ,  Broeks A,  Verhoef S,  Hogervorst FB,  Fasching PA,  Lux MP,  Beckmann MW,  Ekici AB,  Sawyer E,  Tomlinson I,  Kerin M,  Marme F,  Schneeweiss A,  Sohn C,  Burwinkel B,  Guénel P,  Truong T,  Cordina-Duverger E,  Menegaux F,  Bojesen SE,  Nordestgaard BG,  Nielsen SF,  Flyger H,  Milne RL,  Alonso MR,  González-Neira A,  Benítez J,  Anton-Culver H,  Ziogas A,  Bernstein L,  Dur CC,  Brenner H,  Müller H,  Arndt V,  Stegmaier C,  Familial Breast Cancer Study (FBCS),  Justenhoven C,  Brauch H,  Brüning T,  Gene Environment Interaction of Breast Cancer in Germany (GENICA) Network,  Wang-Gohrke S,  Eilber U,  Dörk T,  Schürmann P,  Bremer M,  Hillemanns P,  Bogdanova NV,  Antonenkova NN,  Rogov YI,  Karstens JH,  Bermisheva M,  Prokofieva D,  Khusnutdinova E,  Lindblom A,  Margolin S,  Mannermaa A,  Kataja V,  Kosma VM,  Hartikainen JM,  Lambrechts D,  Yesilyurt BT,  Floris G,  Leunen K,  Manoukian S,  Bonanni B,  Fortuzzi S,  Peterlongo P,  Couch FJ,  Wang X,  Stevens K,  Lee A,  Giles GG,  Baglietto L,  Severi G,  McLean C,  Alnaes GG,  Kristensen V,  Børrensen-Dale AL,  John EM,  Miron A,  Winqvist R,  Pylkäs K,  Jukkola-Vuorinen A,  Kauppila S,  Andrulis IL,  Glendon G,  Mulligan AM,  Devilee P,  van Asperen CJ,  Tollenaar RA,  Seynaeve C,  Figueroa JD,  Garcia-Closas M,  Brinton L,  Lissowska J,  Hooning MJ,  Hollestelle A,  Oldenburg RA,  van den Ouweland AM,  Cox A,  Reed MW,  Shah M,  Jakubowska A,  Lubinski J,  Jaworska K,  Durda K,  Jones M,  Schoemaker M,  Ashworth A,  Swerdlow A,  Beesley J,  Chen X,  kConFab Investigators,  Australian Ovarian Cancer Study Group,  Muir KR,  Lophatananon A,  Rattanamongkongul S,  Chaiwerawattana A,  Kang D,  Yoo KY,  Noh DY,  Shen CY,  Yu JC,  Wu PE,  Hsiung CN,  Perkins A,  Swann R,  Velentzis L,  Eccles DM,  Tapper WJ,  Gerty SM,  Graham NJ,  Ponder BA,  Chenevix-Trench G,  Pharoah PD,  Lathrop M,  Dunning AM,  Rahman N,  Peto J,  Easton DF
Journal: Nat Genet
Date: 2012 Jan 22
Branches: MEB, LGS, OD, OEEB
PubMed ID: 22267197
PMC ID: PMC3653403
Abstract: Breast cancer is the most common cancer among women. To date, 22 common breast cancer susceptibility loci have been identified accounting for ∼8% of the heritability of the disease. We attempted to replicate 72 promising associations from two independent genome-wide association studies (GWAS) in ∼70,000 cases and ∼68,000 controls from 41 case-control studies and 9 breast cancer GWAS. We identified three new breast cancer risk loci at 12p11 (rs10771399; P = 2.7 × 10(-35)), 12q24 (rs1292011; P = 4.3 × 10(-19)) and 21q21 (rs2823093; P = 1.1 × 10(-12)). rs10771399 was associated with similar relative risks for both estrogen receptor (ER)-negative and ER-positive breast cancer, whereas the other two loci were associated only with ER-positive disease. Two of the loci lie in regions that contain strong plausible candidate genes: PTHLH (12p11) has a crucial role in mammary gland development and the establishment of bone metastasis in breast cancer, and NRIP1 (21q21) encodes an ER cofactor and has a role in the regulation of breast cancer cell growth.